CATALOGO DEI PRODOTTI DELLA RICERCA

GAJOFATTO, Alberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.403
EU - Europa 8.232
AS - Asia 5.430
SA - Sud America 712
Continente sconosciuto - Info sul continente non disponibili 250
AF - Africa 244
OC - Oceania 34
Totale 25.305
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.060
RU - Federazione Russa 2.834
SG - Singapore 1.935
CN - Cina 1.740
IT - Italia 1.718
GB - Regno Unito 1.295
BR - Brasile 555
SE - Svezia 451
VN - Vietnam 439
FR - Francia 426
HK - Hong Kong 406
DE - Germania 354
IE - Irlanda 310
FI - Finlandia 296
KR - Corea 183
CA - Canada 171
IN - India 138
BD - Bangladesh 124
NL - Olanda 106
UA - Ucraina 77
EG - Egitto 75
TR - Turchia 73
JP - Giappone 59
ID - Indonesia 55
BE - Belgio 50
ES - Italia 50
PL - Polonia 48
AR - Argentina 47
PK - Pakistan 43
MX - Messico 40
ZA - Sudafrica 40
AT - Austria 38
CH - Svizzera 37
CR - Costa Rica 34
IR - Iran 34
AU - Australia 31
NG - Nigeria 31
IQ - Iraq 30
SA - Arabia Saudita 29
EC - Ecuador 27
IL - Israele 24
LT - Lituania 24
CL - Cile 23
CO - Colombia 19
CZ - Repubblica Ceca 19
SV - El Salvador 19
MA - Marocco 16
JO - Giordania 15
UZ - Uzbekistan 15
VE - Venezuela 15
BJ - Benin 13
PY - Paraguay 13
GR - Grecia 12
HN - Honduras 12
JM - Giamaica 12
TG - Togo 12
MK - Macedonia 11
NI - Nicaragua 11
PH - Filippine 11
TT - Trinidad e Tobago 11
MY - Malesia 10
CW - ???statistics.table.value.countryCode.CW??? 9
LV - Lettonia 9
NO - Norvegia 9
OM - Oman 9
TN - Tunisia 9
AE - Emirati Arabi Uniti 8
DK - Danimarca 8
GT - Guatemala 8
RO - Romania 8
AZ - Azerbaigian 7
DZ - Algeria 7
EU - Europa 7
HU - Ungheria 7
DO - Repubblica Dominicana 6
KE - Kenya 6
PT - Portogallo 6
CI - Costa d'Avorio 5
GP - Guadalupe 5
NP - Nepal 5
PE - Perù 5
SC - Seychelles 5
SD - Sudan 5
BO - Bolivia 4
MD - Moldavia 4
PA - Panama 4
UY - Uruguay 4
AL - Albania 3
AM - Armenia 3
BY - Bielorussia 3
CY - Cipro 3
ET - Etiopia 3
GE - Georgia 3
KG - Kirghizistan 3
LB - Libano 3
LK - Sri Lanka 3
ML - Mali 3
NZ - Nuova Zelanda 3
PR - Porto Rico 3
RS - Serbia 3
Totale 25.014
Salva come PNG Salva come JPEG
Città #
Ashburn 1.561
Dallas 1.119
Moscow 994
Southend 987
Singapore 973
San Jose 873
Chandler 786
Hong Kong 392
Woodbridge 382
Verona 377
Ann Arbor 374
Jacksonville 334
Council Bluffs 331
Beijing 325
Dublin 308
New York 252
The Dalles 234
Los Angeles 170
Houston 169
Wilmington 126
Ho Chi Minh City 122
Lawrence 122
Princeton 122
Milan 119
Helsinki 114
Jinan 110
Nanjing 103
Santa Clara 103
Hebei 88
Shenyang 88
Buffalo 84
Hanoi 84
São Paulo 80
Munich 77
Boardman 73
Columbus 62
Redondo Beach 62
Washington 62
Rome 59
Orem 55
Montreal 54
Tianjin 52
Tokyo 47
Zhengzhou 47
London 45
Atlanta 44
Changsha 44
Lancaster 44
Brussels 43
Dong Ket 43
Redwood City 42
Hangzhou 40
Ningbo 40
Turku 40
Warsaw 40
Carrboro 39
Seattle 39
Cairo 38
Chennai 38
Haikou 37
Nanchang 37
Amsterdam 35
Jakarta 35
Redmond 35
Chicago 34
Guangzhou 34
Bologna 33
Brooklyn 32
Johannesburg 31
Phoenix 31
San José 31
Taiyuan 30
Istanbul 29
Seoul 28
Sindelfingen 28
Taizhou 28
Boston 27
Denver 27
Naples 27
Stockholm 26
Toronto 25
Abuja 24
Frankfurt am Main 23
Fuzhou 21
Catania 20
Da Nang 20
Dearborn 20
Falls Church 20
Paris 20
Tehran 20
Jiaxing 19
San Francisco 19
Shanghai 19
Vilnius 19
Florence 18
Norwalk 18
Nuremberg 18
Padova 18
Poplar 18
Vienna 18
Totale 14.727
Salva come PNG Salva come JPEG
Nome #
Tolebrutinib. Bruton tyrosine kinase (BTK) inhibitor Treatment of multiple sclerosis 664
Psicologia positiva e disabilità: affrontare le sfide del futuro nell'adulto con disabilità acquisita, cronica e progressiva 487
Analisi delle alterazioni funzionali dell’arto superiore e dell’attività muscolare mediante emgs in pazienti con sclerosi multipla: uno studio “cross-sectional” 368
The effectiveness of combining a home-based Digital motor Telerehabilitation program with conventional therapy in progressive multiple sclerosis: A study protocol for a multicenter, randomized controlled trial 350
Biopsychosocial model of resilience in young adults with multiple sclerosis (BPS-ARMS): an observational study protocol exploring psychological reactions early after diagnosis 327
Gestione degli eventi avversi dei farmaci modificanti il decorso della malattia nella sclerosi multipla 298
A bio-psycho-social co-created intervention for young adults with multiple sclerosis (ESPRIMO): rationale and study protocol for a feasibility study 298
A randomized controlled trial of IV immunoglobulin in patients with postpolio syndrome. 286
Clinical spectrum and IgG subclass analysis of anti-myelin oligodendrocyte glycoprotein antibody-associated syndromes: a multicenter study 283
A Case-control study of myelin oligodendrocyte glycoprotein and CD45 polymorphisms in multiple sclerosis in Verona, Italy 252
Can the degree of meningeal inflammation and cortical pathology be used to stratify early progressive MS patients? 252
An exploratory panel of cerebrospinal fluid biomarkers compared to standard diagnostic evaluation in initial demyelinating events suggestive of multiple sclerosis 251
EFFETTI DI UN TRAINING DI INTEGRAZIONE SENSORI – MOTORIA SUI DISTURBI DELL’EQUILIBRIO IN PAZIENTI CON SCLEROSI MULTIPLA: UNO STUDIO RANDOMIZZATO CONTROLLATO 250
Two sisters with Leukoencephalopathy, hearing loss and retinopathy: a familial case of Susac's Syndrome? 249
Neurofilament light chain serum levels reflect disease severity in MOG-Ab associated disorders 243
Insights for fostering resilience in young adults with multiple sclerosis in the aftermath of the COVID-19 emergency: an Italian survey 241
Antibody response against HERV-W env surface peptides differentiates multiple sclerosis and neuromyelitis optica spectrum disorder 239
Prevalence of multiple sclerosis in Verona, Italy: an epidemiologic and genetic study 237
A multicenter study on the diagnostic significance of a single cerebrospinal fluid IgG band 234
Clinical and biomarker assessment of demyelinating events suggesting multiple sclerosis. 233
QTc interval in patients with multiple sclerosis: an inference from the insula of Reil? 233
GLI EFFETTI DI DUE DIVERSI TIPI DI TRATTAMENTO MOTORIO SULLE FUNZIONI COGNITIVE IN PAZIENTI CON SCLEROSI MULTIPLA 232
“If You Can’t Control the Wind, Adjust Your Sail”: Tips for Post-Pandemic Benefit Finding from Young Adults Living with Multiple Sclerosis. A Qualitative Study 231
Intravenous immunoglobulin for post-polio syndrome: a randomized double-blind, placebo-controlled study 230
Levofloxacin-induced hemichorea-hemiballism in a patient with previous thalamic infarction 226
A case of multifocal CIS with unusual MRI features suggestive of Balo's concentric sclerosis 224
Cognitive onset in multiple sclerosis 224
Un caso di sclerosi multipla con esordio "tumor-like" e decorso benigno 223
A case of acute fulminant multiple sclerosis treated with alemtuzumab 223
Are cerebrospinal fluid biomarkers useful in predicting the prognosis of multiple sclerosis patients? 222
Relevance of antibodies to myelin oligodendrocyte glycoprotein in CSF of seronegative cases 221
A case of multiple sclerosis and necrotizing autoimmune myopathy with anti-SRP antibodies 220
Assessment of outcome predictors in first-episode acute myelitis: a retrospective study of 53 cases. 218
An active case of radiologically isolated syndrome: from MRI detection to multiple sclerosis 218
2017 McDonald criteria for multiple sclerosis: Earlier diagnosis with reduced specificity? 218
Risk factors for post-polio syndrome among an Italian population: a case-control study. 217
A panel of exploratory CSF biomarkers in patients with an initial demyelinating event of the CNS: does it add relevant information to usual work-up? 217
Brentuximab vedotin: axonal microtubule's Apollyon 216
Correlation between cerebrospinal fluid markers of neurodegeneration and MRI measures of gray matter pathology in multiple sclerosis 211
Antibody response against HERV-W in patients with MOG-IgG associated disorders, multiple sclerosis and NMOSD 206
Benign course of tumour-like multiple sclerosis. Report of five cases and literature review. 204
High-intensity robot-assisted hand training in individuals with multiple sclerosis: a randomized, controlled, single-blinded trial 203
e-ESPRIMO: An e-health biopsychosocial intervention for young adults with Multiple sclerosis and medium/high disability. Co-creation phase 202
Characterization of Upper Limb Impairments at Body Function, Activity, and Participation in Persons With Multiple Sclerosis by Behavioral and EMG Assessment: A Cross-Sectional Study 200
A multicentRE observational analysiS of PErsistenCe to Treatment in the new multiple sclerosis era: the RESPECT study 197
Late-onset multiple sclerosis presenting with cognitive dysfunction and severe cortical/infratentorial atrophy. 196
Benign multiple sclerosis: physical and cognitive impairment follow distinct evolutions 196
Amyloid myopathy: an intriguing diagnosis 196
Are natalizumab and fingolimod analogous second-line options for the treatment of relapsing-remitting multiple sclerosis? A clinical practice observational study. 193
EFFECTIVENESS OF A SENSORIMOTOR INTEGRATION TRAINING ON BALANCE DISORDERS IN PATIENTS WITH MULTIPLE SCLEROSIS: A RANDOMIZED CONTROLLED TRIAL 192
Prevalence of multiple sclerosis in Verona, Italy: an epidemiological and genetic study. 189
Epilepsy in multiple sclerosis: The role of temporal lobe damage 189
Physical disability and cognitive impairment evolution in benign multiple sclerosis: a five years prospective study 188
Response to Nagai et al. 187
HPV-related papillary squamous cell carcinoma of the tonsil during treatment with fingolimod 187
Acute cardiovascular dysfunction in multiple sclerosis: report of two cases and literature review 186
Effects of high-intensity robot-assisted training in hand function recovery and adl independence in individuals with multiple sclerosis: A randomized controlled single-blinded trial 185
Regional distribution and evolution of grey matter changes in different MS phenotypes: a 5-year longitudinal study 182
Serum and CSF neurofilament light chain levels in antibody-mediated encephalitis 181
Long-term clinical, cognitive and MRI characteristics of patients with untreated benign multiple sclerosis: a natural history study 178
Increase of CSF inflammatory profile in a case of highly active multiple sclerosis 178
Increased cortical lesion load and intrathecal inflammation is associated with oligoclonal bands in multiple sclerosis patients: a combined CSF and MRI study 177
Clinical efficacy, safety, and tolerability of fingolimod for the treatment of relapsing-remitting multiple sclerosis 175
Up-regulated serum miR-128-3p in progressive and relapse-free multiple sclerosis patients 174
Dimethyl fumarate vs Teriflunomide: an Italian time-to-event data analysis 173
Promoting participatory research in chronicity: The ESPRIMO biopsychosocial intervention for young adults with multiple sclerosis 172
Effects of high-intensity robot-assisted hand training on upper limb recovery and muscle activity in individuals with multiple sclerosis: a randomized, controlled, single-blinded trial 171
Evaluating upper upper limb dysfunctions in patients with multiple sclerosis: an electromyography cross sectional study 171
Clinical and demographic predictors of response to first-line therapies in relapsing-remitting multiple sclerosis 168
Mycobacterium avium subspecies paratuberculosis and myelin basic protein specific epitopes are highly recognized by sera from patients with Neuromyelitis optica spectrum disorder 168
Cerebrospinal fluid markers in sporadic Creutzfeldt-Jakob disease. 166
Neurological complications of HIV infection in pre-HAART and HAART era: a retrospective study 166
"Better explanations" in multiple sclerosis diagnostic workup: A 3-year longitudinal study 166
Sensory integration balance training in patients with multiple sclerosis: A randomized, controlled trial 160
The diagnosis of multiple sclerosis: pinpointing the concept of "no better explanation" 159
Physicochemical properties of Aβ peptides in cerebrospinal fluid of Alzheimer’s disease patients 158
Diagnostic features of initial demyelinating events associated with serum MOG-IgG 158
Increased cortical lesion load and CSF cytokines in oligoclonal band positive MS patients 157
Inflammatory intrathecal profiles and cortical damage in multiple sclerosis 157
A multicenter survey on access to care in Multiple Sclerosis-related trigeminal neuralgia 157
Sativex in resistant multiple sclerosis spasticity: Discontinuation study in a large population of Italian patients (SA.FE. study) 156
Changing therapeutic strategies and persistence to disease-modifying treatments in a population of multiple sclerosis patients from Veneto region, Italy 156
Two sisters with leukoencephalopathy, hearing loss and retinopathy: a familial case of Susac's syndrome? 154
Regional distribution and evolution of gray matter damage in different populations of multiple sclerosis patients 153
Prognostic value of multimodal evoked potentials in multiple sclerosis: the EP score. 151
Increased cerebrospinal fluid cystatin C may predict disability after acute myelitis 151
HCV-related nervous system disorders. 150
Resting-state functional connectivity in multiple sclerosis patients receiving nabiximols for spasticity 149
Long survival and clinical stability in Marburg's variant multiple sclerosis. 148
Refractory trigeminal neuralgia responsive to nabiximols in a patient with multiple sclerosis 147
Early predictors of recovery, symptom recurrence, conversion to multiple sclerosis and long-term disability after acute myelitis 146
Brain Volume Measures in Adults with MOG-Antibody-Associated Disease: A Longitudinal Multicenter Study 144
Hepatitis C virus-associated neurocognitive and neuropsychiatric disorders: Advances in 2015 144
Prognostic factors of acute partial transverse myelitis. 142
Long lesions on initial spinal cord MRI predict a final diagnosis of acute disseminated encephalomyelitis versus multiple sclerosis in children 140
Do patients' and referral centers' characteristics influence multiple sclerosis phenotypes? Results from the Italian multiple sclerosis and related disorders register 138
Study protocol on advance care planning in multiple sclerosis (ConCure-SM): intervention construction and multicentre feasibility trial 137
Risk of disease relapse following COVID-19 vaccination in patients with AQP4-IgG-positive NMOSD and MOGAD 137
Ofatumumab for relapsing forms of multiple sclerosis 136
Switching multiple sclerosis patients with breakthrough disease to second-line therapy. 134
Totale 20.547
Salva come PNG Salva come JPEG
Categoria #
all - tutte 83.558
article - articoli 78.498
book - libri 0
conference - conferenze 3.006
curatela - curatele 0
other - altro 618
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.436
Totale 167.116
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022507 0 0 0 0 27 23 11 74 36 32 74 230
2022/20232.274 153 291 212 372 175 483 30 142 246 30 88 52
2023/20241.867 65 114 181 157 241 402 92 154 20 107 178 156
2024/20253.312 169 200 201 486 174 148 188 178 478 246 274 570
2025/202610.224 680 484 1.092 1.534 2.521 610 863 490 850 580 247 273
2026/20272.008 133 228 462 1.079 106 0 0 0 0 0 0 0
Totale 25.305